Get the Stockscreener App
6.88
1.57%
-0.11
After Hours:
6.84
-0.04
-0.58%
Kamada Ltd stock is traded at $6.88, with a volume of 35,837.
It is down -1.57% in the last 24 hours and up +14.10% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$6.99
Open:
$6.98
24h Volume:
35,837
Relative Volume:
0.19
Market Cap:
$382.98M
Revenue:
$154.57M
Net Income/Loss:
$15.07M
P/E Ratio:
25.48
EPS:
0.27
Net Cash Flow:
$10.92M
1W Performance:
+3.30%
1M Performance:
+14.10%
6M Performance:
+14.67%
1Y Performance:
+23.74%
1-Day Range:
$6.83
$7.09
1-Week Range:
$6.60
$7.0999
52-Week Range:
$4.74
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
6.88 | 382.98M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025 - GlobeNewswire
Kamada Ltd. to report Q1 2025 financial results on May 14 - Investing.com Nigeria
Kamada to Release Q1 2025 Financial Results on May 14 - TipRanks
JPMorgan Chase & Co. Invests $67,000 in Kamada Ltd. (NASDAQ:KMDA) - Defense World
Kamada Launches Post-Marketing Research Program for CYTOGAM - TipRanks
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM® - GlobeNewswire
Major Breakthrough: Kamada Initiates 10 Clinical Studies to Transform Organ Transplant CMV Treatment - Stock Titan
Geode Capital Management LLC Raises Position in Kamada Ltd. (NASDAQ:KMDA) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Kamada Expands Specialty Plasma Collection Capabilities with New San Antonio Facility - citybuzz -
Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity - The Globe and Mail
Renaissance Technologies LLC Lowers Holdings in Kamada Ltd. (NASDAQ:KMDA) - Defense World
Kamada Is Bringing Relief To Those With Rare And Serious ConditionsKamada (NASDAQ:KMDA) - Benzinga
Despite shrinking by ₪175m in the past week, Kamada (TLV:KMDA) shareholders are still up 21% over 3 years - simplywall.st
Kamada Ekadashi 2025: Know the date, timings, significance, puja vidhi, and more - The Indian Express
Kamada Ltd. (NASDAQ:KMDA) Short Interest Up 61.8% in March - MarketBeat
Kamada (NASDAQ:KMDA) Downgraded by StockNews.com to “Buy” - Defense World
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders - GlobeNewswire
Kamada Ltd. announces dividend tax details By Investing.com - Investing.com Australia
Kamada Ltd. announces dividend tax details - Investing.com
Kamada Announces Tax Ruling on Special Cash Dividend - TipRanks
Kamada Shareholders Alert: How to Save on Dividend TaxKey Deadlines Revealed - Stock Titan
Kamada (NASDAQ:KMDA) Earns Buy Rating from Analysts at Benchmark - The AM Reporter
Kamada (NASDAQ:KMDA) Coverage Initiated at Benchmark - Defense World
Kamada Ltd’s Growth at Risk: Manufacturing Capacity and Expansion Challenges Loom Large - MSN
Benchmark Initiates Coverage of Kamada (KMDA) with Buy Recommendation - Nasdaq
Benchmark raises Kamada stock target to $15, initiates with Buy By Investing.com - Investing.com Canada
Benchmark raises Kamada stock target to $15, initiates with Buy - Investing.com
Kamada Ltd. expands plasma collection with new Texas site By Investing.com - Investing.com South Africa
Kamada at Sidoti Small-Cap Conference: Strategic Growth and Future Plans - Investing.com Australia
Kamada Expands Plasma Collection With New Texas Facility -March 19, 2025 at 09:37 am EDT - Marketscreener.com
Kamada opens plasma center with 50,000-liter capacity - Investing.com
Kamada Ltd. expands plasma collection with new Texas site - Investing.com
Kamada Expands Plasma Collection Operations with New San Antonio Center - TipRanks
Kamada opens third plasma collection center in San Antonio, Texas - TipRanks
Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas - GlobeNewswire
Kamada's New Texas Plasma Center to Generate $10M Annual Revenue - StockTitan
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
StockNews.com Upgrades Kamada (NASDAQ:KMDA) to Strong-Buy - Defense World
Kamada Delivers Record Financial Performance, Projects Continued Growth in 2025 - citybuzz -
Kamada Announces Dividend After Record-Breaking Year, Anticipates Further Double-Digit Growth - Financial Content
Kamada Ltd. Reports Record 2024 Financial Results - TipRanks
HC Wainwright Has Pessimistic View of Kamada FY2025 Earnings - Defense World
HC Wainwright Reaffirms “Buy” Rating for Kamada (NASDAQ:KMDA) - Defense World
Research Analysts Set Expectations for Kamada Q1 Earnings - Defense World
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida - The Manila Times
H.C. Wainwright maintains $11 target on Kamada stock By Investing.com - Investing.com South Africa
Kamada Ltd. (NASDAQ:KMDA) Q4 2024 Earnings Call Transcript - Insider Monkey
Kamada: Q4 Earnings Snapshot - Barchart
Kamada Ltd (KMDA) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - Yahoo Finance
Kamada Ltd (KMDA) Q4 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):